Announcements Trials
Browse Landscape

Phase

Phase 1/2 3Phase 1 2

Status

Completed 5Unknown 3Terminated 3Withdrawn 1Suspended 1Recruiting 1

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 2Sarcoma 1Plasma cell 1

Conditions

Stomach Neoplasms 2Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Keratoacanthoma familial 1Desmoid Tumors 1Colorectal Neoplasms 1Camurati-Engelmann Syndrome 1

Interventions

Cyclophosphamide 1488Cisplatin 1410Paclitaxel 1316Radiotherapy 1259Carboplatin 1247Gemcitabine 1214Docetaxel 1110Bevacizumab 1029Fluorouracil 894Doxorubicin 786Dexamethasone 746Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 673Etoposide 673Irinotecan 634Filgrastim 621Cytarabine 584Leucovorin 578Nivolumab 557Vincristine 510Prednisone 474Cetuximab 464Bortezomib 457Erlotinib Hydrochloride 456Trastuzumab 448Methotrexate 437Lenalidomide 426Pemetrexed 419

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × Interventional × vactosertib × Clear all
NCT03724851 2025-03-25

Vactosertib in Combination with Pembrolizumab in Metastatic Colorectal or Gastric Cancer

MedPacto, Inc.

Phase 1/2 Completed
120 enrolled
Gastrointestinal

Stomach Neoplasms, Colorectal Neoplasms

NCT03698825 2024-12-09

TEW-7197 with Paclitaxel for the Treatment of Metastatic Gastric Cancer

MedPacto, Inc.

Phase 1/2 Completed
62 enrolled
Gastrointestinal

Stomach Neoplasms

NCT03143985 2024-05-24

Vactosertib in Combination w/ Pomalidomide in Relapsed or Relapsed and Refractory Multiple Myeloma

Case Comprehensive Cancer Center

Phase 1 Completed
18 enrolled
Plasma cell

Multiple Myeloma

NCT03802084 2024-05-13

A Study to Evaluate the Safety and Efficacy of Vactosertib and Imatinib in Patients With Advanced Desmoid Tumor

Yonsei University

Phase 1/2 Completed
24 enrolled
Sarcoma

Desmoid Tumors

NCT02160106 2019-05-09

First in Human Dose Escalation Study of Vactosertib (TEW-7197) in Subjects With Advanced Stage Solid Tumors

MedPacto, Inc.

Phase 1 Completed
35 enrolled

Keratoacanthoma familial, Camurati-Engelmann Syndrome, Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡